Restart Life Sciences Corp (HEAL) Stock Price & News

All values in CAD	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	-	-	134,55 миң	331,16 миң
Cost of goods sold	-	-	72,62 миң	200,46 миң
Cost of revenue	-	-	72,62 миң	200,46 миң
Research and development expenses	-	-	5,00 миң	-3,75 миң
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	167,38 миң	308,52 миң	256,02 миң	426,52 миң
Operating expense	167,84 миң	309,00 миң	372,83 миң	1,10 млн
Total operating expenses	167,84 миң	309,00 миң	445,44 миң	1,30 млн
Operating income	-167,84 миң	-309,00 миң	-310,89 миң	-972,69 миң
Other non operating income	1,61 миң	-7,44 миң	-8,37 миң	-12,41 миң
EBT including unusual items	-210,98 миң	-157,32 миң	-326,14 миң	-1,02 млн
EBT excluding unusual items	-166,23 миң	-316,44 миң	-319,59 миң	-996,55 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-210,98 миң	-157,32 миң	-326,14 миң	-1,02 млн
Net profit margin	-	-	-242,39%	-307,00%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-540,00	-11,10 миң
Net interest expenses	-	-	-540,00	-11,10 миң
Depreciation and amortization charges	-	-	-	-
EBITDA	-167,38 миң	-308,52 миң	-309,55 миң	-971,36 миң
Gain or loss from assets sale	-	-	-	-

Finance